Invitrogen™ Human OX40L ELISA Kit

Ref.: BL-RE-106580Manufacturer ref.: EH356RB 96 tests
€734.00 excl. VAT

Human OX40L quantitates human OX40L in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human OX40L.

Accession number
Ath1 ; Ath-1 ; athérosclérose 1 ; ligand CD134 ; CD134L ; CD252 ; glycoprotéine Gp34 ; GP34 ; ligand antigène O x 40 ; ligand O x 40 ; O x 40 L ; OX-40 L ; O x 4 OL ; glycoprotéine transcriptionnellement activée par TAX 1 ; glycoprotéine transcriptionnelle activée par tax 1 (34 kD) ; ligand de glycoprotéine activée par tax 1 ; Tnfsf4 ; TNLG2B ; membre de la superfamille (ligand) des facteurs de nécrose tumorale 4, superfamille (ligand) des facteurs de nécrose tumorale, membre 4 ; ligand du facteur de nécrose tumorale 2 B ; membre de la superfamille de ligand des facteurs de nécrose tumorale 4 ; membre de la superfamille des facteur de nécrose tumorale 4 ; Txgp1 ; Txgp1l
Dose range
61-15 000 pg/ml
Sensitivity of the dosage
61 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human OX40L quantitates human OX40L in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human OX40L.

Human OX40L quantitates human OX40L in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human OX40L.

TNFSF4, a member of the tumour necrosis factor superfamily, is a homotrimer protein bound to the II membrane and not bound by covalence. It is expressed on antigen cells, such as dendritic and activated B cells, as well as on other cells such as vascular endothelial cells, mastocytes and natural killer cells. TNFSF4 signals, specifically via the TNFRSF4 receiver, are mainly expressed on CD4+ T cells, but also on some activated CD8+ T cells. TNFRSF4/TNNFSF4 works as a co-stimulation signal, necessary for productive interaction between antigen cells and their target T cells. It improves cell proliferation and survival and increases expression of RANTES, IL-2, IL-3 and IFNgamma. Signing of TNFRSF4/TNNFSF4 plays an important role in immunotolerance.

Sensitivity

Sensitivity of dosage: 61 pg/ml.

Measurement range

Dosing range: 61 to 15,000 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: OX40L (CD252).

Samples

Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; serum, 50 µl; plasma, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17164653
Specifications
Accession numberAth1; Ath-1; atherosclerosis 1; ligand CD134; CD134L; CD252; Gp34 glycoprotein; GP34; antigen ligand O x 40; ligand O x 40; O x 40 L; OX-40 L; O x 4 OL; transcriptionally activated glycoprotein by TAX 1; transcriptionally activated glycoprotein by tax 1 (34 kD); glycoligand
Dose range61-15 000 pg/ml
Sensitivity of the dosage61 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P23510
Gene symbol(s)Tnfsf4
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity96 tests
Regulatory statusUse exclusively for research
TargetOX40L (CD252)
Test time1 h 20 min
Physical characteristics
Volume of sampleSupernatant, 50 µl; serum, 50 µl; plasma, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH356RB
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.